dr mary claire haver and glp 1 GLP-1 medications were never designed to be a quick fix., In this episode of unPAUSED, Dr. Michelle Gordon (@doctormichellegordon) explains why GLP-1s are intended to treat obesity as the chronic Your GLP-1 “GPS Roadmap”: How

Understanding these potential risks is essential for informed decision-making and appropriate monitoring

Renal denervation attenuates the sodium retention and hypertension associated with obesity

Add it gradually so it does not cause bloating

Read in context, it is a secondary, exploratory outcome from a Phase 2 trial whose primary endpoint, change in cerebral glucose metabolism, was negative, and whose cognitive signal was modest

Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, Hashemzade S, Asghari Jafarabadi M, Montazeri V, Keshavarz SA, Darabi M

For those who enjoy predictive insights, session analytics can highlight average spin cost, bonus hit rate, and volatility band, enabling smarter decisions and goal setting